|
Market Closed -
Nasdaq
20:00:00 26/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 29.18 USD | +15.89% |
|
+25.83% | +90.59% |
| 10-26 | Top Midday Gainers | MT |
| 10-26 | Wedbush Adjusts Price Target on Xencor to $45 From $30, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENCOR, INC. | Bio Therapeutic Drugs | +15.89% | +25.83% | +90.59% | +120.89% | -24.83% | 1.87B |  | | |
- Stock Market
- Stocks
- XNCR Stock
- Charts Xencor, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
